BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16093575)

  • 1. Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivity.
    van Tits LJ; Arioglu-Oral E; Sweep CG; Smits P; Stalenhoef AF; Tack CJ
    Neth J Med; 2005; 63(7):250-5. PubMed ID: 16093575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
    Tack CJ; Ong MK; Lutterman JA; Smits P
    Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.
    Nolan JJ; Ludvik B; Beerdsen P; Joyce M; Olefsky J
    N Engl J Med; 1994 Nov; 331(18):1188-93. PubMed ID: 7935656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin and its response to thiazolidinediones are associated with insulin-mediated glucose metabolism in type 2 diabetic patients and their first-degree relatives.
    Hulstrøm V; Højlund K; Vinten J; Beck-Nielsen H; Levin K
    Diabetes Obes Metab; 2008 Nov; 10(11):1019-28. PubMed ID: 18284435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state.
    Jellema A; Plat J; Mensink RP
    Eur J Clin Invest; 2004 Nov; 34(11):766-73. PubMed ID: 15530150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians.
    Raji A; Gerhard-Herman MD; Williams JS; O'connor ME; Simonson DC
    Diabet Med; 2006 May; 23(5):537-43. PubMed ID: 16681563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is dermolipectomy effective in improving insulin action and lowering inflammatory markers in obese women?
    Rizzo MR; Paolisso G; Grella R; Barbieri M; Grella E; Ragno E; Grella R; Nicoletti G; D'Andrea F
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):253-8. PubMed ID: 16117810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus.
    Kadoglou NP; Iliadis F; Angelopoulou N; Perrea D; Ampatzidis G; Liapis CD; Alevizos M
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):837-43. PubMed ID: 18043308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese.
    Ghanim H; Garg R; Aljada A; Mohanty P; Kumbkarni Y; Assian E; Hamouda W; Dandona P
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1306-12. PubMed ID: 11238525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial variations of plasma inflammatory markers in abdominally obese men.
    Blackburn P; Després JP; Lamarche B; Tremblay A; Bergeron J; Lemieux I; Couillard C
    Obesity (Silver Spring); 2006 Oct; 14(10):1747-54. PubMed ID: 17062804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice.
    Furuya DT; Poletto AC; Favaro RR; Martins JO; Zorn TM; Machado UF
    Metabolism; 2010 Mar; 59(3):395-9. PubMed ID: 19800637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children.
    Reinehr T; Stoffel-Wagner B; Roth CL; Andler W
    Metabolism; 2005 Sep; 54(9):1155-61. PubMed ID: 16125526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
    Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth.
    Kim ES; Im JA; Kim KC; Park JH; Suh SH; Kang ES; Kim SH; Jekal Y; Lee CW; Yoon YJ; Lee HC; Jeon JY
    Obesity (Silver Spring); 2007 Dec; 15(12):3023-30. PubMed ID: 18198311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes.
    Luzio SD; Dunseath G; Owens DR
    Horm Metab Res; 2002 May; 34(5):271-4. PubMed ID: 12063642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.
    Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H
    J Cardiol; 2003 Apr; 41(4):183-90. PubMed ID: 12728539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.